| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Actinium Pharmaceuticals, Inc. (ATNM) has 1 insider with recent SEC Form 4 filings, including 4 buys and 29 sells. ATNM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 184.5K | $241.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2017 | O'Loughlin Steve | Principal Financial Officer | Buy | 3,500 | $1.17 | $4,095.00 | New | |
| Jun 15, 2017 | Berger Mark Stanley | Chief Medical Officer | Buy | 5,000 | $1.11 | $5,550.00 | New | |
| Dec 30, 2016 | Seth Sandesh | Executive Chairman | Buy | 5,000 | $0.88 | $4,400.00 | +16.7% | |
| Dec 12, 2016 | Seth Sandesh | Executive Chairman | Buy | 5,000 | $0.98 | $4,900.00 | +20.0% | |
| Aug 31, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 192,927 | $1.83 | $352,372.39 | -0.3% | |
| Aug 29, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 50,000 | $1.71 | $85,495.02 | -0.3% | |
| Aug 16, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 9,468 | $1.72 | $16,286.96 | - | |
| Jul 12, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 3,100 | $1.80 | $5,581.00 | - | |
| Jul 11, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 21,990 | $1.80 | $39,582.00 | -0.2% | |
| Jul 6, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 20,840 | $1.81 | $37,762.20 | -0.1% |